Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study

Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study

<p><strong>Background</strong> Symptomatic hand osteoarthritis is more common in women than in men, and its incidence increases around the age of menopause, implicating oestrogen deficiency. No randomised controlled trials of hormone replacement therapy (HRT) have been done in peop...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Williams, JAE, Chester-Jones, M, Minns Lowe, C, Goff, MV, Francis, A, Brewer, G, Marian, I, Morris, SL, Warwick, D, Eldridge, L, Julier, P, Gulati, M, Barker, KL, Barber, VS, Black, J, Woollacott, S, Mackworth-Young, C, Glover, V, Lamb, SE, Vincent, TL, Vincent, K, Dutton, SJ, Watt, FE
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2022

Míreanna comhchosúla

Hand Osteoarthritis: investigating Pain Effects in a randomised placebo-controlled feasibility study of estrogen-containing therapy (HOPE-e): report on the primary feasibility outcomes
de réir: Williams, JAE, et al.
Foilsithe / Cruthaithe: (2022)

Is treating painful hand osteoarthritis with hormone replacement therapy feasible? Primary results from a randomised controlled trial in post-menopausal women
de réir: Williams, J, et al.
Foilsithe / Cruthaithe: (2022)

How should we best measure participant-reported ‘average hand pain’: comparison of two methods from a randomized placebo-controlled feasibility study of post-menopausal women with hand osteoarthritis
de réir: Williams, JA, et al.
Foilsithe / Cruthaithe: (2023)

Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial
de réir: Marian, IR, et al.
Foilsithe / Cruthaithe: (2021)

Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
de réir: Komm BS, et al.
Foilsithe / Cruthaithe: (2012-03-01)

Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial
de réir: Ioana R. Marian, et al.
Foilsithe / Cruthaithe: (2021-06-01)

The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
de réir: Stefano Lello, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
de réir: Kagan R, et al.
Foilsithe / Cruthaithe: (2016-04-01)

Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination
de réir: Mirkin S, et al.
Foilsithe / Cruthaithe: (2013-08-01)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
de réir: Kawate H, et al.
Foilsithe / Cruthaithe: (2011-06-01)

Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice
de réir: Emmanuelle Noirrit, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Menopausal oestrogen use and breast cancer.
de réir: Beral, V
Foilsithe / Cruthaithe: (1980)

Menopausal oestrogen use and breast cancer.
de réir: Beral, V
Foilsithe / Cruthaithe: (1980)

Multiple Routes to Oestrogen Antagonism
de réir: Hilary R. Glover, et al.
Foilsithe / Cruthaithe: (2010-10-01)

Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer
de réir: Rhynelle S. Dmello, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Bazedoxifene does not share estrogens effects on IgG sialylation.
de réir: Priti Gupta, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Update on bazedoxifene: A novel selective estrogen receptor modulator
de réir: Diane M Biskobing
Foilsithe / Cruthaithe: (2007-10-01)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
de réir: Darb&agrave; J, et al.
Foilsithe / Cruthaithe: (2013-07-01)

Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation
de réir: Renu Sudhakar, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM
de réir: Samantha M. Wightman, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
de réir: Jia Wei, et al.
Foilsithe / Cruthaithe: (2019-02-01)

The role of oestrogen and oestrogen-calcium axis in endometrial carcinoma
de réir: Jingyi Zhou, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
de réir: Pathum Thilakasiri, et al.
Foilsithe / Cruthaithe: (2019-03-01)

Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health.
de réir: Karen Lee Ann Chen, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients
de réir: Soo-Kyung Cho, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
de réir: Jia Wei, et al.
Foilsithe / Cruthaithe: (2019-08-01)

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
de réir: Cogliano, V, et al.
Foilsithe / Cruthaithe: (2005)

Complex role of oestrogens in the risk and severity of rheumatoid arthritis in menopause
de réir: Maurizio Cutolo, et al.
Foilsithe / Cruthaithe: (2023-04-01)

The influence of sex hormones on musculoskeletal pain and osteoarthritis
de réir: Gulati, M, et al.
Foilsithe / Cruthaithe: (2023)

Hand osteoarthritis: clinical phenotypes, molecular mechanisms and disease management
de réir: Marshall, M, et al.
Foilsithe / Cruthaithe: (2018)

Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling
de réir: Changyou Shi, et al.
Foilsithe / Cruthaithe: (2024-09-01)

88116 Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women
de réir: Kara Marlatt, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
de réir: Rossini M, et al.
Foilsithe / Cruthaithe: (2013-07-01)

Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats
de réir: Hidetsugu Maekawa, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women.
de réir: Key, T, et al.
Foilsithe / Cruthaithe: (1996)

Oestrogen enforces the integrity of blood vessels in the bone during pregnancy and menopause
de réir: Rodrigues, J, et al.
Foilsithe / Cruthaithe: (2022)

Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project
de réir: Black, J, et al.
Foilsithe / Cruthaithe: (2024)

Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project
de réir: Joanna Black, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Bazedoxifene Plays a Protective Role against Inflammatory Injury of Endothelial Cells by Targeting CD40
de réir: Wenmin Song, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers
de réir: Lee MH, et al.
Foilsithe / Cruthaithe: (2023-04-01)